Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Many Medications: Understanding the Biologic Management of Psoriasis

Jason Liebowitz, MD, FACR  |  June 15, 2023

ORLANDO, FLORIDA — Given the intersection between rheumatology and dermatology for many patients with autoimmune diseases, it’s helpful to hear from specialists in both fields regarding disease management strategies.

Mixed Results for Rezpegaldesleukin in Patients with Active SLE

Michele B. Kaufman, PharmD, BCGP  |  June 13, 2023

In a clinical trial, patients with active systemic lupus erythematosus (SLE) did not experience a reduction in disease activity with the addition of rezpegaldesleukin to their standard treatments. However, some patient populations did see improvements in their disease activity compared with the placebo-treated group.

FDA Issues Updated Prescribing Information for Opioids & Over-the-Counter Naloxone

Michele B. Kaufman, PharmD, BCGP  |  June 13, 2023

New prescribing guidance has been issued by the FDA for immediate-release and extended-release/long-acting opioids for pain management. The agency also announced multiple label updates, which include changes to the Boxed Warnings.

What’s Next for Telehealth after the COVID-19 Public Health Emergency?

Emily A. Johnson, JD  |  June 10, 2023

Do you remember where you were when the COVID-19 Public Health Emergency (PHE) was declared on Jan. 31, 2020? While it may seem like yesterday, you would be forgiven for not recalling your exact location over three years ago during what felt like an incredible whirlwind for the healthcare industry. One possible location you may…

Summer 2023’s Awards, Appointments & Announcements in Rheumatology

Gretchen Henkel  |  June 10, 2023

Arthritis Foundation Establishes Dr. Herbert S.B. Baraf Award for Excellence in Arthritis Care In October 2022 at its annual Commitment to a Cure Gala, the metropolitan Washington, D.C., chapter of the Arthritis Foundation presented its medical honoree, Herbert S.B. Baraf, MD, FACP, MACR, with the inaugural eponymous Dr. Herbert S.B. Baraf Award for Excellence in…

Rheum After 5: Dr. Nigil Haroon, Photographer

Carol Patton  |  June 10, 2023

Roughly six years ago, Nigil Haroon, MD, PhD, MBA, division head of rheumatology at the University Health Network, Toronto, traveled almost 9,000 miles from his home to Papua, New Guinea. His plan was to photograph the Raggiana bird-of-paradise, which can only be found in the tropical forests of eastern New Guinea. He spent about two…

Case Report: A Patient Presents with Digital Ischemia & Gangrene

Nedal Darwish, MD, Mohamed Manaa, MD, Griffin Reyes, MD, & James G. Freeman, MD  |  June 10, 2023

Defined by the presence of antiphospholipid antibodies (aPL) in individuals with clinical evidence of thrombosis or pregnancy morbidity, antiphospholipid syndrome (APS) is a systemic autoimmune thrombophilia. Clinical thrombosis, which should be confirmed by objective validated criteria (e.g., imaging studies or histopathology), can occur in the arterial, venous or small vessel vasculature and is not limited…

How to Discuss Anti-Inflammatory Diets & Supplements with Your Patients

Emily Molina, MD  |  June 9, 2023

My patients ask me almost daily what kind of diet they should be on, or if there are certain supplements they should try. And a growing amount of evidence shows lifestyle and dietary factors may contribute to disease risk and outcomes in rheumatic disease. Thus, rheumatologists and rheumatology professionals are being called upon by patients…

Don’t Let a Good Mentor Get Away

Bharat Kumar, MD, MME, FACP, FAAAAI, RhMSUS  |  June 9, 2023

“When you get a good mentor, don’t let ’em be the one that got away.” Richard Brasington Jr., MD, FACP, MACR, told me this about a decade ago when I was a rheumatology fellowship applicant and first met him. It was clear the statement was influenced by his love of fishing. Dr. Brasington’s office was…

Community Practice Council Holds First Meeting

Joseph Cantrell, JD  |  June 6, 2023

The April 29 meeting included 13 CPC members, representatives from the ACR Board of Directors and the chairs of the ACR Committee on Rheumatologic Care and its Insurance Subcommittee. The group is part of an expanded effort to ensure the ACR is meeting the needs of rheumatologists in independent practice.

  • « Previous Page
  • 1
  • …
  • 67
  • 68
  • 69
  • 70
  • 71
  • …
  • 816
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences